Citadel Advisors - PASITHEA THERAPEUTICS CORP ownership

PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F111. A total of 8 filers reported holding PASITHEA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PASITHEA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$19012,8260.00%
Other shareholders
PASITHEA THERAPEUTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Kepos Capital LP 400,000$320,0000.02%
ARMISTICE CAPITAL, LLC 1,000,000$800,0000.01%
UBS Group AG 45$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PASITHEA THERAPEUTICS CORP shareholders